Strong evidence suggests that inflammasome signaling and GSDMS-induced pyroptosis are activated in PBMCs of aMCI and AD patients. Additionally, the proinflammatory cytokine IL-1β has been demonstrated to have a strong association with the pathophysiology of aMCI and AD. Here, IL1B is linked to Alzheimer disease.